Rubin Eyal 4
4 · Protalix BioTherapeutics, Inc. · Filed Sep 24, 2024
Insider Transaction Report
Form 4
Rubin Eyal
Sr. VP & CFO
Transactions
- Award
Common Stock
2024-09-23+99,010→ 669,010 total(indirect: By Trust)
Footnotes (2)
- [F1]Represents fully-vested restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.